サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1409801

低分子創薬の世界市場レポート 2024年

Small Molecule Drug Discovery Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
低分子創薬の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

低分子創薬市場規模は近年力強く成長しています。2023年の574億1,000万米ドルから2024年には631億5,000万米ドルへと、CAGR10.0％で拡大します。低分子創薬分野の実績は、いくつかの重要な要因に起因しています。これらには、薬剤の再利用に焦点を当てた取り組み、既存の薬剤を新たな治療用途に活用すること、創薬プロセスにおける自動化の統合、製薬業界における研究開発（R&D）への投資の増大、薬剤開発に対する規制当局の支援と促進、ハイスループットスクリーニング技術の大幅な進歩などが含まれます。これらの要因が総合的に、低分子創薬の進歩・進展に寄与しました。

低分子創薬市場規模は、今後数年で急成長が見込まれます。2028年には956億3,000万米ドルに成長し、CAGRは10.9%に達すると思われます。今後予想される成長は、いくつかの要因によってもたらされます。これらには、新規かつ革新的な治療標的の同定、患者に焦点を当てた創薬アプローチへのシフト、医薬品とデバイスの組み合わせ製品の開発、医薬品研究におけるリアルワールドエビデンスの活用、医薬品開発への薬理ゲノミクスの統合、世界の健康問題がもたらす継続的な課題などが含まれます。この予測期間に予想される主な動向としては、フラグメントベースの創薬手法の採用、人工知能の創薬研究への取り込み、RNA標的治療薬の進歩、業界内の共同研究やパートナーシップの促進、ドラッグデリバリー技術の革新、オルガノイドや3D細胞培養モデルの利用拡大などが挙げられます。

予想される慢性疾患の増加は、低分子創薬市場の成長を促進します。慢性疾患は、1年以上持続し、継続的な治療を必要とすることが特徴で、HIV、がん、感染症、心臓病、腎臓病などの疾患が含まれます。低分子医薬品はこれらの慢性疾患の治療に有効であることが証明されており、一般に患者にとって費用対効果が高いです。米国国立衛生研究所（NIH）の2023年の報告によると、米国では、少なくとも1つの慢性疾患を持つ50歳以上の人口が99.5％増加し、2020年の7,152万2,000人から2050年には1億4,266万人になると予想されています。さらに、多疾患併存者数は91.16%増加し、2020年の783万400人から2050年には1,496万8,000人に達すると予測されます。その結果、慢性疾患の罹患率の増加が低分子創薬市場拡大の原動力となっています。

ヘルスケアにおける研究開発の促進を目的とした政府のイニシアチブは、低分子創薬市場の成長を促進すると予測されています。こうした取り組みには、ヘルスケアの課題に対処し、社会の前向きな変化を促進するために、政府当局がさまざまなレベルで実施する具体的な行動、プログラム、政策が含まれます。2022年、英国政府はヘルスケア社会介護省（Department of Health and Social Care）から報告されたように、ヘルスケアの調査と製造を強化するために2億6,000万ポンド（米国2億7,065万米ドル）の資金提供を約束しました。BEISとDHSCが提供するこの資金は、革新的なプライバシー保護プラットフォームと臨床研究サービスを通じて、診断と治療におけるNHS主導の医療研究を支援します。さらに6,000万ポンド（6,360万米ドル）が、英国におけるライフサイエンス製造業の拡大を支援するために割り当てられました。その結果、ヘルスケアにおける研究開発に焦点を当てた政府のイニシアチブは、低分子創薬市場を推進する上で極めて重要な役割を果たしています。

2023年の低分子創薬市場で最大の地域は北米でした。予測期間中、低分子創薬市場レポートでは欧州が最も急成長する地域と予測されています。低分子創薬市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 低分子創薬市場の特徴

第3章 低分子創薬市場の動向と戦略

第4章 低分子創薬市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の低分子創薬市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 低分子創薬市場セグメンテーション

  • 世界の低分子創薬市場、医薬品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 低分子薬
  • 生物学的製剤
  • 世界の低分子創薬市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ハイスループットスクリーニング
  • 薬理ゲノミクス
  • コンビナトリアルケミストリー
  • ナノテクノロジー
  • その他
  • 世界の低分子創薬市場、治療領域別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 腫瘍学
  • 中枢神経系
  • 心臓血管
  • 呼吸器系
  • 代謝障害
  • 胃腸
  • その他
  • 世界の低分子創薬市場、プロセス/フェーズ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ターゲット IDまたは検証
  • ヒットの生成と選択
  • リードの特定
  • リードの最適化
  • 世界の低分子創薬市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 製薬会社
  • 受託研究機関
  • その他

第7章 低分子創薬市場の地域および国分析

  • 世界の低分子創薬市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の低分子創薬市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋の低分子創薬市場

第9章 中国の低分子創薬市場

第10章 インドの低分子創薬市場

第11章 日本の低分子創薬市場

第12章 オーストラリアの低分子創薬市場

第13章 インドネシアの低分子創薬市場

第14章 韓国の低分子創薬市場

第15章 西欧の低分子創薬市場

第16章 英国の低分子創薬市場

第17章 ドイツの低分子創薬市場

第18章 フランスの低分子創薬市場

第19章 イタリアの低分子創薬市場

第20章 スペインの低分子創薬市場

第21章 東欧の低分子創薬市場

第22章 ロシアの低分子創薬市場

第23章 北米の低分子創薬市場

第24章 米国の低分子創薬市場

第25章 カナダの低分子創薬市場

第26章 南米低分子創薬市場

第27章 ブラジルの低分子創薬市場

第28章 中東の低分子創薬市場

第29章 アフリカの低分子創薬市場

第30章 低分子創薬市場の競合情勢と企業プロファイル

  • 低分子創薬市場の競合情勢
  • 低分子創薬市場の企業プロファイル
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • AstraZeneca
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company

第31章 世界の低分子創薬市場の競合ベンチマーキング

第32章 世界の低分子創薬市場競争ダッシュボード

第33章 低分子創薬市場における主要な合併と買収

第34章 低分子創薬市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r11339

“Small Molecule Drug Discovery Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule drug discovery? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The small molecule drug discovery market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Drug Type: Small Molecule Drugs; Biologic Drugs
  • 2) By Technology: High Throughput Screening; Pharmacogenomics; Combinatorial Chemistry; Nanotechnology; Others
  • 3) By Therapeutic Area: Oncology; Central Nervous System; Cardiovascular; Respiratory; Metabolic Disorders; Gastrointestinal; Others
  • 4) By Process/Phase: Target ID Or Validation; Hit Generation And Selection; Lead Identification; Lead Optimization
  • 5) By End-User: Pharmaceutical Companies; Contract Research Organizations; Others
  • Companies Mentioned: Pfizer Inc.; GlaxoSmithKline plc; AstraZeneca; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Small molecule drug discovery involves the identification of medicines characterized by their low molecular weight, allowing them to easily penetrate cells and either cure or prevent diseases.

The primary categories within small molecule drug discovery are small molecule drugs and biologic drugs. Small molecule drugs are organic chemicals with relatively low molecular weights (less than 900 daltons) that affect biological processes. Various technologies employed in this field include high throughput screening, pharmacogenomics, combinatorial chemistry, nanotechnology, and others. These technologies find application in therapeutic areas such as oncology, central nervous system disorders, cardiovascular diseases, respiratory conditions, metabolic disorders, gastrointestinal ailments, among others. The drug discovery process involves phases such as target identification or validation, hit generation and selection, lead identification, and lead optimization, utilized by pharmaceutical companies, contract research organizations, and other entities in the industry.

The small molecule drug discovery market research report is one of a series of new reports from The Business Research Company that provides small molecule drug discovery market statistics, including small molecule drug discovery industry global market size, regional shares, competitors with a small molecule drug discovery market share, detailed small molecule drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule drug discovery industry. This small molecule drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small molecule drug discovery market size has grown strongly in recent years. It will grow from $57.41 billion in 2023 to $63.15 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The historical growth in the field of small molecule drug discovery can be attributed to several key factors. These include initiatives focused on drug repurposing, leveraging existing drugs for new therapeutic uses, the integration of automation in the drug discovery process, augmented investment in research and development (R&D) within the pharmaceutical industry, regulatory support and facilitation for drug development, and significant advancements in high-throughput screening technologies. These factors collectively contributed to advancements and progress in the small molecule drug discovery landscape.

The small molecule drug discovery market size is expected to see rapid growth in the next few years. It will grow to $95.63 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The anticipated growth in the upcoming period is driven by several factors. These include the identification of new and innovative therapeutic targets, a shift towards patient-focused drug discovery approaches, the development of drug-device combination products, the utilization of real-world evidence in drug research, the integration of pharmacogenomics into drug development, and the ongoing challenges posed by global health issues. Key trends expected in this forecast period involve the adoption of fragment-based drug discovery methods, the incorporation of artificial intelligence into drug research, advancements in RNA-targeted therapeutics, fostering collaborations and partnerships within the industry, innovations in drug delivery techniques, and the increased utilization of organoids and 3D cell culture models.

The anticipated rise in chronic diseases is set to propel the growth of the small molecule drug discovery market. Chronic diseases, characterized by lasting a year or longer and requiring continuous medical care, include conditions such as HIV, cancer, infections, heart disease, and renal disease. Small-molecule medications prove to be effective in treating these chronic conditions and are generally more cost-effective for patients. According to a report from the National Institutes of Health (NIH) in 2023, the United States is expected to witness a 99.5% increase in the number of people aged 50 and older with at least one chronic illness, rising from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity is projected to rise by 91.16%, reaching 14.968 million in 2050 from 7.8304 million in 2020. Consequently, the growing incidence of chronic diseases is a driving force behind the expansion of the small molecule drug discovery market.

Government initiatives aimed at promoting research and development in healthcare are anticipated to drive the growth of the small molecule drug discovery market. These initiatives involve specific actions, programs, or policies undertaken by government authorities at various levels to address healthcare challenges and foster positive changes in society. In 2022, the UK government, as reported by the Department of Health and Social Care, committed £260 million (US $270.65 million) in funding to enhance healthcare research and manufacturing. This funding, provided by BEIS and DHSC, supports NHS-led health research in diagnostics and treatment through innovative privacy-preserving platforms and clinical research services. An additional £60 million (US $63.60 million) was allocated to support the expansion of life sciences manufacturing in the UK. Consequently, government initiatives focused on research and development in healthcare play a pivotal role in propelling the small molecule drug discovery market.

Technological innovations emerge as a prominent trend in the small molecule drug discovery market, with major companies concentrating on the development of new products. For instance, in January 2023, Dotmatics, a US-based provider of a digital science platform, introduced the Small Molecule Drug Discovery Solution. Uniquely designed with an integrated scientific R&D platform featuring pre-configured workflows and expanded data management capabilities, this solution aims to reduce operational inefficiencies and expedite the process of transforming data into actionable insights. The focus on technological advancements underscores the commitment of industry leaders to drive advancements in the small molecule drug discovery field.

Prominent companies within the small molecule drug discovery sector are actively engaging in strategic partnerships as a key strategy to drive revenues. These collaborations often serve as catalysts for innovation by harnessing the combined expertise of different entities. In a noteworthy example, in November 2023, Evommune, a non-profit organization based in the United States, joined forces with Accutar Biotechnology, a US-based biotechnology company, in a strategic partnership focused on AI-based drug discovery, specifically targeting chronic inflammatory diseases. This collaborative effort aims to capitalize on Accutar's proprietary AI platform and Evommune's specialized expertise to identify novel small molecule drug candidates.

A significant partnership occurred in July 2022 when GSK Plc., a prominent pharmaceutical and biotechnology company based in the UK, acquired Sierra Oncology Inc. for a substantial deal valued at 1.9 billion dollars. This strategic acquisition plays a crucial role in expanding GSK's advanced cancer portfolio, underscoring its commitment to improving patient outcomes and maximizing shareholder value. Sierra Oncology, a US-based clinical-stage drug development company, specializes in advancing targeted therapeutics for the treatment of cancer patients. The collaboration is expected to enable GSK to establish a sustainable process for innovative therapeutics, utilizing modalities such as small molecules, antibodies, antibody-drug conjugates, and cell therapy. This strategic move reinforces GSK's position in the small molecule drug discovery landscape while broadening its capabilities in addressing critical healthcare challenges.

Major companies operating in the small molecule drug discovery market report are Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 21st Century Therapeutics Inc., 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Immunocure Inc., Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, CelerisTx, Clinuvel Pharmaceuticals, Corcept Therapeutics, Doloromics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Surface Ophthalmics, Pardes Biosciences, Xynomic Pharmaceuticals, AfaSci, Zevra Therapeutics, Saniona, UNION therapeutics, Tetra Pharm Technologies, Pharmacosmos, Allarity Therapeutics, Xellia Pharmaceuticals, Cyteir Therapeutics, BigHat Biosciences .

North America was the largest region in the small molecule drug discovery market in 2023. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the small molecule drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small molecule drug discovery market consists of sales of diphenhydramine, aspirin, and other "medicine cabinet" drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Small Molecule Drug Discovery Market Characteristics

3. Small Molecule Drug Discovery Market Trends And Strategies

4. Small Molecule Drug Discovery Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Small Molecule Drug Discovery Market Size and Growth

  • 5.1. Global Small Molecule Drug Discovery Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Small Molecule Drug Discovery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Small Molecule Drug Discovery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Small Molecule Drug Discovery Market Segmentation

  • 6.1. Global Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Small Molecule Drugs
  • Biologic Drugs
  • 6.2. Global Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • High Throughput Screening
  • Pharmacogenomics
  • Combinatorial Chemistry
  • Nanotechnology
  • Others
  • 6.3. Global Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Central Nervous System
  • Cardiovascular
  • Respiratory
  • Metabolic Disorders
  • Gastrointestinal
  • Others
  • 6.4. Global Small Molecule Drug Discovery Market, Segmentation By Process/Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Target ID Or Validation
  • Hit Generation And Selection
  • Lead Identification
  • Lead Optimization
  • 6.5. Global Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Others

7. Small Molecule Drug Discovery Market Regional And Country Analysis

  • 7.1. Global Small Molecule Drug Discovery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Small Molecule Drug Discovery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Small Molecule Drug Discovery Market

  • 8.1. Asia-Pacific Small Molecule Drug Discovery Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Small Molecule Drug Discovery Market

  • 9.1. China Small Molecule Drug Discovery Market Overview
  • 9.2. China Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Small Molecule Drug Discovery Market

  • 10.1. India Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Small Molecule Drug Discovery Market

  • 11.1. Japan Small Molecule Drug Discovery Market Overview
  • 11.2. Japan Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Small Molecule Drug Discovery Market

  • 12.1. Australia Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Small Molecule Drug Discovery Market

  • 13.1. Indonesia Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Small Molecule Drug Discovery Market

  • 14.1. South Korea Small Molecule Drug Discovery Market Overview
  • 14.2. South Korea Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Small Molecule Drug Discovery Market

  • 15.1. Western Europe Small Molecule Drug Discovery Market Overview
  • 15.2. Western Europe Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Small Molecule Drug Discovery Market

  • 16.1. UK Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Small Molecule Drug Discovery Market

  • 17.1. Germany Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Small Molecule Drug Discovery Market

  • 18.1. France Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Small Molecule Drug Discovery Market

  • 19.1. Italy Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Small Molecule Drug Discovery Market

  • 20.1. Spain Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Small Molecule Drug Discovery Market

  • 21.1. Eastern Europe Small Molecule Drug Discovery Market Overview
  • 21.2. Eastern Europe Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Small Molecule Drug Discovery Market

  • 22.1. Russia Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Small Molecule Drug Discovery Market

  • 23.1. North America Small Molecule Drug Discovery Market Overview
  • 23.2. North America Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Small Molecule Drug Discovery Market

  • 24.1. USA Small Molecule Drug Discovery Market Overview
  • 24.2. USA Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Small Molecule Drug Discovery Market

  • 25.1. Canada Small Molecule Drug Discovery Market Overview
  • 25.2. Canada Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Small Molecule Drug Discovery Market

  • 26.1. South America Small Molecule Drug Discovery Market Overview
  • 26.2. South America Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Small Molecule Drug Discovery Market

  • 27.1. Brazil Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Small Molecule Drug Discovery Market

  • 28.1. Middle East Small Molecule Drug Discovery Market Overview
  • 28.2. Middle East Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Small Molecule Drug Discovery Market

  • 29.1. Africa Small Molecule Drug Discovery Market Overview
  • 29.2. Africa Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Small Molecule Drug Discovery Market Competitive Landscape And Company Profiles

  • 30.1. Small Molecule Drug Discovery Market Competitive Landscape
  • 30.2. Small Molecule Drug Discovery Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. GlaxoSmithKline plc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AstraZeneca
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Boehringer Ingelheim International GmbH
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bristol-Myers Squibb Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Small Molecule Drug Discovery Market Competitive Benchmarking

32. Global Small Molecule Drug Discovery Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Small Molecule Drug Discovery Market

34. Small Molecule Drug Discovery Market Future Outlook and Potential Analysis

  • 34.1 Small Molecule Drug Discovery Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Small Molecule Drug Discovery Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Small Molecule Drug Discovery Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer